Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
New York Medical College
With
Johns Hopkins University
Columbia University
New York University
Age
0–11
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Kawasaki disease presumptive diagnosis defined according AHA criteria;
Signed informed consent and patient assent (if applicable)
Diagnosis of KD and initiation of defibrotide within 96 hours from the conclusion of IVIG treatment
Age: 0 - 11 years old
High risk category defined as patient meeting ≥2 of the following criteria: male, age \<6 months or \>8yrs, IVIG-resistance, Fever lasting greater than 10 days, prior to diagnosis, Coronary artery aneurysms, and/or Laboratory tests indicating worse systemic inflammation
PT and PTT within institutional normal limits
Platelet count ≥100,000/mm3
You may not be if
History of Grade III or IV hemorrhage or active bleeding;
Previous Grade II-IV hypersensitivity to defibrotide
